Viewing StudyNCT00003659



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003659
Status: COMPLETED
Last Update Posted: 2017-10-24
First Post: 1999-11-01

Brief Title: Fludarabine Cyclophosphamide and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
stage IV chronic lymphocytic leukemia View
stage II chronic lymphocytic leukemia View
stage III chronic lymphocytic leukemia View